Similar articles

• Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.

  Falkenstein K, Dunn S. Falkenstein K, et al. Transplant Proc. 1998 Aug;30(5):1964-6. doi: 10.1016/s0041-1345(98)00497-7. Transplant Proc. 1998. PMID: 9723354 No abstract available.
• Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.

  Alberti D, Reding R, Otte JB, Falchetti D, Rigamonti W, Caccia G, Sokal E, de Ville de Goyet J. Alberti D, et al. Transplant Proc. 1998 Aug;30(5):1858-60. doi: 10.1016/s0041-1345(98)00459-x. Transplant Proc. 1998. PMID: 9723310 No abstract available.
• Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.

  Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR. Reggiani P, et al. Transplant Proc. 1998 Aug;30(5):1855-6. doi: 10.1016/s0041-1345(98)00457-6. Transplant Proc. 1998. PMID: 9723308 Clinical Trial. No abstract available.
• Neoral is superior to FK 506 in liver transplantation.

  Levy GA. Levy GA. Transplant Proc. 1998 Aug;30(5):1812-5. doi: 10.1016/s0041-1345(98)00442-4. Transplant Proc. 1998. PMID: 9723293 Review. No abstract available.
• Clinical use of FK 506 in liver transplantation.

  Klintmalm GB. Klintmalm GB. Transplant Proc. 1996 Apr;28(2):974-6. Transplant Proc. 1996. PMID: 8623484 Review.